Company intelligence / Profile preview

YuceBio

Shenzhen, Guangdong Province, China

Ownership: Private
Development stage: Commercial

Overview

YuceBio specializes in biomarker development and validation, neoantigen discovery for personalized cancer vaccines and immunotherapies, companion diagnostics development, and big data analytics for oncology. The company operates advanced medical laboratories with CAP certification and ISO9001 accreditation. It supports drug developers with central lab testing, biological sample analysis at all clinical stages (GLP/GCP compliant), GMP manufacturing capabilities for diagnostics/biologics production.

Therapeutic areas: Oncology
Modalities: Cell therapyGene therapyBiologicCompanion diagnostic
Industry: Molecular Diagnostics

Partnerships

MGI Tech (sequencing technology partnership)BGI GroupAcademic collaborations via participation in ICGC/CCGC/TESLA consortia

Beyond the preview

Go deeper on YuceBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on YuceBio.

Explore the full profile